Integral Health Asset Management, LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 1773206 New York, NY

Back to LNTH Full portfolio

Position in LNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,481,250

+$2,826,250 QoQ

Shares Held

125,000

+25.0% QoQ

Ownership

0.192%

of shares outstanding

% of Portfolio

0.50%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Integral Health Asset Management, LLC holds $42,403,750 across 3 Drug Manufacturers - Specialty & Generic names. LNTH ranks #3 (22.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	150,000	$19,761,000
2	ELAN	Elanco Animal Health Inc	550,000	$13,161,500
3	LNTH	Lantheus Holdings, Inc. This page	125,000	$9,481,250

All Filings in LNTH

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,481,250	125,000	+25.0%	Shares	Sole	2026-05-15
2025-12-31	$6,655,000	100,000	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.